FindTrial
Sign In

"To Study The Effect Of Hingu Churna In Ovulationâ??

â??Randomized Clinical Endpoint Study To Assess The Effect Of Hingu Churna In Stree Pushpa Janana w.s.r. To Ovarian Follicle Developmentâ??

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2022/10/046207
Enrollment
148
Registered
2022-10-06
Start date
Unknown
Completion date
Unknown
Last updated
2023-05-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: E00-E89- Endocrine, nutritional and metabolic diseases

Interventions

None listed

Sponsors

None listed

Eligibility

Inclusion criteria

Inclusion criteria: 1. Females with irregular and Scanty menses due to anovulatory cycle 2. WHO Group II anovulatory cycles i.e. Normogonadotrophic Hypogonadism, most common of which is PCOD 3. Pre-diagnosed patients of anovulatory cycles

Exclusion criteria

Exclusion criteria: 1. Age less than 18 years and more than 35 years 2. WHO Type I and Type III Anovulatory Disorders 3. Patients with infertility cause other than follicular development 4. Endometriosis 5. Untreated and Uncontrolled Hyper Prolactinemia 6. Hypo and Hyper Gonadotropin, level 7. Uterine Fibroid 8. Ovarian Tumor 9. Any other non-ovarian Causes of abnormality in ovarian follicle Development.

Design outcomes

Secondary

MeasureTime frame
There are no secondary outcomes to be measuredTimepoint: Not applicable—

Primary

MeasureTime frame
Primary outcomes that will be assessed- Ovarian follicle developmentTimepoint: 3 menstrual cycles—

Countries

India

Contacts

Public ContactPallavi Ashok Chandanshiv

YMT Ayurvedic Medical College & Hospital. P.G.Institute

drmangeshpatil21@gmail.com9324071592

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026